Survival of Trial-Like and Non–Trial-Like Patients With Immunotherapy in Advanced Hepatocellular Carcinoma in Real World: A Collaborative Multicenter Indian Study (IMHEP)

PURPOSEImmune checkpoint inhibitors (ICIs) is the initial line of management in advanced hepatocellular carcinoma (HCC), but survivals in the real world are not known.MATERIALS AND METHODSA retrospective study of patients with advanced HCC receiving ICIs (as first-line therapy or as later lines of t...

Full description

Bibliographic Details

Published in:	JCO Global Oncology
Main Authors:	Anant Ramaswamy, Anand Kulkarni, George John, Amit Rauthan, Shekhar Patil, Ajay Duseja, Vineet Talwar, Senthil J. Rajappa, Nikhil Ghadyalpatil, Manav Wadhawan, Akash Shukla, Vamshi M. Krishna, Sujay Srinivas, Sunil Taneja, K. Mary Sravani, Sahaj Rathi, Prabhat Bhargava, Vikas Ostwal
Format:	Article
Language:	English
Published:	American Society of Clinical Oncology 2023-09-01
Online Access:	https://ascopubs.org/doi/10.1200/GO.23.00215